Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

DVAX vs SIGA

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
DVAX
Dynavax Technologies Corporation

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • US
Market Cap$1.82B
5Y Perf.+153.3%
SIGA
SIGA Technologies, Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • US
Market Cap$337M
5Y Perf.+11.9%

DVAX vs SIGA — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
DVAX logoDVAX
SIGA logoSIGA
IndustryDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & Generic
Market Cap$1.82B$337M
Revenue (TTM)$331M$95M
Net Income (TTM)$-43M$23M
Gross Margin83.2%68.6%
Operating Margin3.2%25.1%
Forward P/E31.6x2.8x
Total Debt$254M$795K
Cash & Equiv.$96M$154.97T

DVAX vs SIGALong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

DVAX
SIGA
StockMay 20Feb 26Return
Dynavax Technologie… (DVAX)100253.3+153.3%
SIGA Technologies, … (SIGA)100111.9+11.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: DVAX vs SIGA

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: SIGA leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Dynavax Technologies Corporation is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
DVAX
Dynavax Technologies Corporation
The Income Pick

DVAX is the clearest fit if your priority is income & stability and growth exposure.

  • beta 0.75
  • Rev growth 19.4%, EPS growth 5.0%, 3Y rev CAGR -14.2%
  • Lower volatility, beta 0.75, Low D/E 42.6%, current ratio 10.80x
Best for: income & stability and growth exposure
SIGA
SIGA Technologies, Inc.
The Long-Run Compounder

SIGA carries the broadest edge in this set and is the clearest fit for long-term compounding.

  • 7.2% 10Y total return vs DVAX's 10.0%
  • Lower P/E (2.8x vs 31.6x)
  • 24.6% margin vs DVAX's -13.1%
Best for: long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthDVAX logoDVAX19.4% revenue growth vs SIGA's -31.8%
ValueSIGA logoSIGALower P/E (2.8x vs 31.6x)
Quality / MarginsSIGA logoSIGA24.6% margin vs DVAX's -13.1%
Stability / SafetyDVAX logoDVAXBeta 0.75 vs SIGA's 1.15
DividendsSIGA logoSIGA12.8% yield; 4-year raise streak; the other pay no meaningful dividend
Momentum (1Y)DVAX logoDVAX+41.9% vs SIGA's +0.6%
Efficiency (ROA)SIGA logoSIGA0.0% ROA vs DVAX's -4.6%, ROIC 0.0% vs -0.4%

DVAX vs SIGA — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

DVAXDynavax Technologies Corporation
FY 2024
H E P L I S A V B
96.8%$268M
Other Revenue
3.2%$9M
SIGASIGA Technologies, Inc.
FY 2025
Product Sales and Supportive Services
93.1%$88M
Research and Development
6.9%$7M

DVAX vs SIGA — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLDVAXLAGGINGSIGA

Income & Cash Flow (Last 12 Months)

Evenly matched — DVAX and SIGA each lead in 3 of 6 comparable metrics.

DVAX is the larger business by revenue, generating $331M annually — 3.5x SIGA's $95M. SIGA is the more profitable business, keeping 24.6% of every revenue dollar as net income compared to DVAX's -13.1%. On growth, DVAX holds the edge at +17.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricDVAX logoDVAXDynavax Technolog…SIGA logoSIGASIGA Technologies…
RevenueTrailing 12 months$331M$95M
EBITDAEarnings before interest/tax$19M$24M
Net IncomeAfter-tax profit-$43M$23M
Free Cash FlowCash after capex$81M$49M
Gross MarginGross profit ÷ Revenue+83.2%+68.6%
Operating MarginEBIT ÷ Revenue+3.2%+25.1%
Net MarginNet income ÷ Revenue-13.1%+24.6%
FCF MarginFCF ÷ Revenue+24.4%+51.5%
Rev. Growth (YoY)Latest quarter vs prior year+17.7%-95.3%
EPS Growth (YoY)Latest quarter vs prior year+90.9%-111.8%
Evenly matched — DVAX and SIGA each lead in 3 of 6 comparable metrics.

Valuation Metrics

SIGA leads this category, winning 6 of 6 comparable metrics.

At 14.2x trailing earnings, SIGA trades at a 82% valuation discount to DVAX's 77.5x P/E.

MetricDVAX logoDVAXDynavax Technolog…SIGA logoSIGASIGA Technologies…
Market CapShares × price$1.8B$337M
Enterprise ValueMkt cap + debt − cash$2.0B-$154.97T
Trailing P/EPrice ÷ TTM EPS77.50x14.24x
Forward P/EPrice ÷ next-FY EPS est.31.59x2.76x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple503.23x-6387033.21x
Price / SalesMarket cap ÷ Revenue6.56x3.56x
Price / BookPrice ÷ Book value/share3.46x0.00x
Price / FCFMarket cap ÷ FCF30.24x6.91x
SIGA leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

SIGA leads this category, winning 7 of 8 comparable metrics.

SIGA delivers a 0.0% return on equity — every $100 of shareholder capital generates $0 in annual profit, vs $-8 for DVAX. SIGA carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to DVAX's 0.43x. On the Piotroski fundamental quality scale (0–9), DVAX scores 6/9 vs SIGA's 5/9, reflecting solid financial health.

MetricDVAX logoDVAXDynavax Technolog…SIGA logoSIGASIGA Technologies…
ROE (TTM)Return on equity-8.1%0.0%
ROA (TTM)Return on assets-4.6%0.0%
ROICReturn on invested capital-0.4%+0.0%
ROCEReturn on capital employed-0.4%0.0%
Piotroski ScoreFundamental quality 0–965
Debt / EquityFinancial leverage0.43x0.00x
Net DebtTotal debt minus cash$159M-$154.97T
Cash & Equiv.Liquid assets$96M$154.97T
Total DebtShort + long-term debt$254M$795,169
Interest CoverageEBIT ÷ Interest expense-5.28x
SIGA leads this category, winning 7 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

DVAX leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in DVAX five years ago would be worth $17,455 today (with dividends reinvested), compared to $10,096 for SIGA. Over the past 12 months, DVAX leads with a +41.9% total return vs SIGA's +0.6%. The 3-year compound annual growth rate (CAGR) favors DVAX at 12.4% vs SIGA's 6.8% — a key indicator of consistent wealth creation.

MetricDVAX logoDVAXDynavax Technolog…SIGA logoSIGASIGA Technologies…
YTD ReturnYear-to-date+0.8%-15.5%
1-Year ReturnPast 12 months+41.9%+0.6%
3-Year ReturnCumulative with dividends+42.1%+21.7%
5-Year ReturnCumulative with dividends+74.5%+1.0%
10-Year ReturnCumulative with dividends+10.0%+722.2%
CAGR (3Y)Annualised 3-year return+12.4%+6.8%
DVAX leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

DVAX leads this category, winning 2 of 2 comparable metrics.

DVAX is the less volatile stock with a 0.75 beta — it tends to amplify market swings less than SIGA's 1.15 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DVAX currently trades 98.5% from its 52-week high vs SIGA's 48.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricDVAX logoDVAXDynavax Technolog…SIGA logoSIGASIGA Technologies…
Beta (5Y)Sensitivity to S&P 5000.75x1.15x
52-Week HighHighest price in past year$15.73$9.62
52-Week LowLowest price in past year$9.20$4.29
% of 52W HighCurrent price vs 52-week peak+98.5%+48.9%
RSI (14)Momentum oscillator 0–10075.744.0
Avg Volume (50D)Average daily shares traded5.7M683K
DVAX leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates DVAX as "Buy" and SIGA as "Buy". SIGA is the only dividend payer here at 12.81% yield — a key consideration for income-focused portfolios.

MetricDVAX logoDVAXDynavax Technolog…SIGA logoSIGASIGA Technologies…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$27.00
# AnalystsCovering analysts111
Dividend YieldAnnual dividend ÷ price+12.8%
Dividend StreakConsecutive years of raises4
Dividend / ShareAnnual DPS$0.60
Buyback YieldShare repurchases ÷ mkt cap+5.5%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

SIGA leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). DVAX leads in 2 (Total Returns, Risk & Volatility). 1 tied.

Best OverallDynavax Technologies Corpor… (DVAX)Leads 2 of 6 categories
Loading custom metrics...

DVAX vs SIGA: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is DVAX or SIGA a better buy right now?

For growth investors, Dynavax Technologies Corporation (DVAX) is the stronger pick with 19.

4% revenue growth year-over-year, versus -31. 8% for SIGA Technologies, Inc. (SIGA). SIGA Technologies, Inc. (SIGA) offers the better valuation at 14. 2x trailing P/E (2. 8x forward), making it the more compelling value choice. Analysts rate Dynavax Technologies Corporation (DVAX) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — DVAX or SIGA?

On trailing P/E, SIGA Technologies, Inc.

(SIGA) is the cheapest at 14. 2x versus Dynavax Technologies Corporation at 77. 5x. On forward P/E, SIGA Technologies, Inc. is actually cheaper at 2. 8x.

03

Which is the better long-term investment — DVAX or SIGA?

Over the past 5 years, Dynavax Technologies Corporation (DVAX) delivered a total return of +74.

5%, compared to +1. 0% for SIGA Technologies, Inc. (SIGA). Over 10 years, the gap is even starker: SIGA returned +722. 2% versus DVAX's +10. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — DVAX or SIGA?

By beta (market sensitivity over 5 years), Dynavax Technologies Corporation (DVAX) is the lower-risk stock at 0.

75β versus SIGA Technologies, Inc. 's 1. 15β — meaning SIGA is approximately 54% more volatile than DVAX relative to the S&P 500. On balance sheet safety, SIGA Technologies, Inc. (SIGA) carries a lower debt/equity ratio of 0% versus 43% for Dynavax Technologies Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — DVAX or SIGA?

By revenue growth (latest reported year), Dynavax Technologies Corporation (DVAX) is pulling ahead at 19.

4% versus -31. 8% for SIGA Technologies, Inc. (SIGA). On earnings-per-share growth, the picture is similar: Dynavax Technologies Corporation grew EPS 503. 2% year-over-year, compared to -60. 2% for SIGA Technologies, Inc.. Over a 3-year CAGR, SIGA leads at -5. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — DVAX or SIGA?

SIGA Technologies, Inc.

(SIGA) is the more profitable company, earning 24. 6% net margin versus 9. 9% for Dynavax Technologies Corporation — meaning it keeps 24. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SIGA leads at 25. 1% versus -1. 5% for DVAX. At the gross margin level — before operating expenses — DVAX leads at 82. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is DVAX or SIGA more undervalued right now?

On forward earnings alone, SIGA Technologies, Inc.

(SIGA) trades at 2. 8x forward P/E versus 31. 6x for Dynavax Technologies Corporation — 28. 8x cheaper on a one-year earnings basis.

08

Which pays a better dividend — DVAX or SIGA?

In this comparison, SIGA (12.

8% yield) pays a dividend. DVAX does not pay a meaningful dividend and should not be held primarily for income.

09

Is DVAX or SIGA better for a retirement portfolio?

For long-horizon retirement investors, SIGA Technologies, Inc.

(SIGA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 15), 12. 8% yield, +722. 2% 10Y return). Both have compounded well over 10 years (SIGA: +722. 2%, DVAX: +10. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between DVAX and SIGA?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: DVAX is a small-cap high-growth stock; SIGA is a small-cap deep-value stock. SIGA pays a dividend while DVAX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

DVAX

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 8%
  • Gross Margin > 49%
Run This Screen
Stocks Like

SIGA

Dividend Mega-Cap Quality

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 14%
  • Dividend Yield > 5.1%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform DVAX and SIGA on the metrics below

Revenue Growth>
%
(DVAX: 17.7% · SIGA: -95.3%)
P/E Ratio<
x
(DVAX: 77.5x · SIGA: 14.2x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.